GLP-1 Medications in India: A Complete Guide
Last Updated: 30 August 2026
GLP-1 receptor agonist medications have become one of the most discussed topics in weight management in India. This guide explains what they are, who is generally considered a candidate, and what the consultation process looks like — so you can have a better-informed conversation with a doctor.
What GLP-1 receptor agonist medications are
GLP-1 stands for glucagon-like peptide-1, a hormone your gut releases after you eat. It plays a role in signalling fullness to the brain, slowing how quickly the stomach empties, and supporting the body’s regulation of blood sugar.
GLP-1 receptor agonist medications are prescription medicines that act on the same receptors as this hormone. They were first developed for the management of type 2 diabetes, and some are now also prescribed in the context of weight management. In India they are available only on prescription and only under medical supervision.
Who doctors generally consider a candidate
Clinical eligibility is usually assessed against a combination of body mass index and existing health conditions. The criteria commonly applied are:
- BMI of 30 or above, or
- BMI of 27 or above together with a weight-related health condition, or
- Type 2 diabetes with a BMI of 27 or above
Weight-related conditions in this context typically include high blood pressure, obstructive sleep apnoea, high cholesterol, prediabetes and joint problems linked to weight.
These are general criteria, not a decision. A doctor assesses your full medical history, current medications, family history and previous weight management attempts before considering whether any prescription route is appropriate.
You can work out where you stand against these criteria before your appointment using our GLP-1 Eligibility Checker. It applies the same BMI and health-condition logic described above and produces a summary you can take with you.
When these medications are not suitable
There are recognised situations in which doctors will not prescribe GLP-1 receptor agonist medications. These include a personal or family history of certain thyroid cancers, a history of pancreatitis, pregnancy or planning a pregnancy, and some gastrointestinal conditions.
This is one reason self-assessment tools cannot replace a consultation. A screening question you answer as “not sure” may be the single most important part of your history.
What the consultation process looks like in India
A first appointment usually covers your weight history, current medications, existing conditions and what you have already tried. Expect blood work — typically including HbA1c, thyroid function, liver and kidney markers and a lipid profile.
If a doctor does consider a prescription appropriate, follow-up is part of the process rather than an optional extra. Dose adjustments, monitoring for side effects and periodic bloodwork are standard.
Cost is a practical factor worth raising early. These medications are not typically covered by health insurance in India for weight management, and treatment is generally ongoing rather than short-term.
What to sort out regardless
Whether or not a prescription route turns out to be appropriate for you, the foundations do the heavy lifting: adequate protein, a manageable calorie deficit, sleep, and movement you can sustain.
Two starting points that are useful either way:
- Metabolic Health Assessment — a broader look at where your metabolic risk sits, beyond weight alone.
- PCOS and Diabetes Weight Calculator — for anyone whose weight is complicated by insulin resistance or PCOS, where the picture differs from standard calorie advice.
Questions worth asking your doctor
- Given my history, is a prescription route appropriate at all?
- What would we monitor, and how often?
- What side effects should I expect early, and which ones mean I should call you?
- What happens if I stop?
- What would we do instead if this isn’t suitable for me?